Skip to main content
PolicySpeak
← All files
ESI

European Social Insurance Platform (ESIP)

Other · Belgium · EU Transparency Register 883980785-32

5
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
4
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 784 non-governmental organisations on this site, they rank #188 by legislative files engaged — a count of participation, not a measure of influence.

3.5
declared lobbying FTE
self-declared
—
declared costs / yr (floor)
4
EP accreditations
as declared to the register
2008
in the register since
Register category
Non-governmental organisations
Registered as
European Social Insurance Platform AISBL (ESIP)
Head office
Brussels, Belgium

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track European in PolicySpeak: request access →

Work at European Social Insurance Platform (ESIP)? so we know who speaks for it.

Follow the files European Social Insurance Platform (ESIP) engages with

One email on Tuesdays when a new position is filed on these 3 files, from European Social Insurance Platform (ESIP) or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

European Social Insurance Platform (ESIP) filed 5 positions between 11 Jun 2025 and 24 Jul 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 4 times.

2025 · 2 filed2026 · 3 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 24 Jul 2026PDFsource

The European Social Insurance Platform (ESIP) acknowledges the objectives of revising the EU regulatory framework for medical devices and in-vitro diagnostics, reducing unnecessary administrative burdens and supporting timely access to medical technologies.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025PDFsource

The European Social Insurance Platform (ESIP), representing social and health insurers in the EU including those responsible for the assessment and/or reimbursement of medical devices, notes the European Commissions initiative to present a targeted revision of Regulations (EU) 2017/745 (Medical Devices Regulation, MDR) and (EU) 2017/746 (In Vitro Diagnostics Regulation, IVDR).

European Biotech Actfiled 24 Jul 2026PDFsource

The European Social Insurance Platform (ESIP) and the Medicine Evaluation Committee (MEDEV) support the objective of strengthening Europe's biotechnology and biomanufacturing ecosystem through the EU Biotech Act. Importantly, industrial policy measures must remain compatible with timely patient access, affordable medicines, robust clinical evidence and the long-term sustainability of healthcare systems.

European Biotech Actfiled 11 Jun 2025PDFsource

The European Social Insurance Platform (ESIP), representing national social security and health insurance institutions across Europe, views positively the European Commissions initiatives to boost the EU life sciences sector, particularly the upcoming European Biotech Act.

Health Checks for Cardiovascular diseasesfiled 19 May 2026source

The European Social Insurance Platform (ESIP), representing statutory social security institutions and healthcare payers in Europe, welcomes the Commissions initiative for a Council Recommendation to support Member States improving early detection of cardiovascular diseases (CVD). CVD remains a major public health, social and economic burden.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 64.

Is this your organization?

Everything on this page comes from European Social Insurance Platform (ESIP)’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.